sglt2 inhibitor vs glp 1 How Do (Sodium-Glucose Cotransporter 2) Inhibitors and GLP-1 (Glucagon-Like Peptide-1) Receptor Agonists Reduce Cardiovascular Outcomes? Synergistic Effects of SGLT2 Inhibitors

What this means in practice: the oral health consequences of GLP-1 medications are no longer a niche concern

MC1R, melanogenesis and pigmentation MC1R is dominantly expressed in melanocytes in the skin, in hair follicles and in the iris of the eye

This immune response triggers a hypersensitivity or allergic reaction that then affects the skin

When the road youre trudging on seems all uphill

Clinical guidelines generally support longer-term use for sustained outcomes, but the appropriate duration for how long to take GLP-1 medication should be guided by a prescriber based on individual goals, response to treatment, and overall health